Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / AZN - AstraZeneca's Acquisition of Alexion Is Nearly a Done Deal But Is It a Good Deal?


AZN - AstraZeneca's Acquisition of Alexion Is Nearly a Done Deal But Is It a Good Deal?

AstraZeneca (NASDAQ: AZN) hopes to soon close its planned acquisition of Alexion Pharmaceuticals (NASDAQ: ALXN) . The only hurdle left to jump is obtaining approval from United Kingdom regulators. In this Motley Fool Live video recorded on July 7 , Motley Fool contributors Keith Speights and Brian Orelli discuss whether or not the Alexion acquisition is a good deal for AstraZeneca.

Continue reading

For further details see:

AstraZeneca's Acquisition of Alexion Is Nearly a Done Deal, But Is It a Good Deal?
Stock Information

Company Name: AstraZeneca PLC
Stock Symbol: AZN
Market: NASDAQ
Website: astrazeneca.com

Menu

AZN AZN Quote AZN Short AZN News AZN Articles AZN Message Board
Get AZN Alerts

News, Short Squeeze, Breakout and More Instantly...